Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The objective of this trial is to assess the clinical efficacy of the modified extract (depigmented and polymerized with glutaraldehyde) of the subcutaneous injection of Parietaria Judaica pollen in the treatment of patients affected by allergic rhinitis/rhinoconjunctivitis ( with or without episodic asthma) induced by hypersensitivity to grass pollen, evaluating the score regarding symptoms and consumption of the medication.
Epistemonikos ID: b4bcc5a8cafc333d502af8145c641e4c6b5b8d46
First added on: May 05, 2024